Search results
Mounjaro vs. Ozempic: Which Is Better for Weight Loss?
MediaFeed via AOL· 2 days agoIn one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable...
If You'd Invested $1,000 in Novo Nordisk Stock 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 24 minutes agoBoth it and the related medication Ozempic -- developed and approved as a diabetes drug -- contain...
Is Eli Lilly Stock A Buy Or A Sell As FDA Plans Meeting To Discuss Alzheimer's Drug?
Investor's Business Daily· 6 days agoLike Biogen and Eisai's approved Alzheimer's treatment, Leqembi, donanemab...advisors could focus on...
5 weight-loss drug stocks to watch as Ozempic, Zepbound sales surge
Bankrate via AOL· 7 days agoThe first GLP-1 drug was Byetta (exenatide), approved in 2005 for type 2 diabetes. Almost five years...
Lilly Settles With Spa Selling Mounjaro, Zepbound Knock-Offs
The Wall Street Journal· 19 hours agoEli Lilly has reached its first legal settlement with one of the spas that it had accused in...
Does Medicare Cover Wegovy?
Verywell Health via Yahoo News· 5 days agoIn April, for instance, Eli Lilly announced study results demonstrating Zepbound significantly...is decades old and based on concerns over the safety of...
Is Eli Lilly's Latest Deal a Gamechanger? | The Motley Fool
The Motley Fool· 1 day agoDiabetes and obesity treatments from Novo Nordisk, such as Ozempic, Rybelsus, and Wegovy, are taking...
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
NBC Los Angeles· 1 day agoPatients taking Novo Nordisk's obesity drug Wegovy maintained an average of 10% weight loss for up...
After Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
Morningstar· 2 days agoWith strong pricing power and sales growth of key drugs, here’s what we think of Lilly’s stock. Eli ...
Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows
WHTC 1450 Holland· 5 days ago(Reuters) - About one in eight adults have taken a drug belonging to the GLP-1 class of medications...
